COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04762628


Column Value
Trial registration number NCT04762628
Full text link
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

First author
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Saisei Pharma

Contact
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Not reported

Registration date
Last imported at : Feb. 24, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

2021-02-21

Recruitment status
Last imported at : Aug. 10, 2021, 3:30 p.m.
Source : ClinicalTrials.gov

Completed

Study design
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Adaptive

Masking
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Open label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

multi-center

Study aim
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Treatment

Inclusion criteria
Last imported at : March 1, 2023, 9:56 a.m.
Source : ClinicalTrials.gov

inclusion criteria: patients found to have positive rt-pcr for sars-cov-2 in any specimen on 4 days prior to randomization, those who are hospitalized with evidence of respiratory disease during clinical assessment or imaging male or non-pregnant female adult ≥18 years of age subject (or legally authorized representative) provides informed consent prior to initiation of any study procedures subject (or legally authorized representative) understands and agrees to comply with planned study procedures has illness of not more than 7 days duration at the time of enrolment does not require immediate resuscitation or mechanical ventilation respiration rate ≤ 29 per minute spo2 ≤ 95% on room air agrees to not participate in another clinical trial through day 29

Exclusion criteria
Last imported at : March 1, 2023, 9:56 a.m.
Source : ClinicalTrials.gov

pregnant or breastfeeding women known allergy to dairy products on corticosteroids for covid-19 therapy at the time of screening subjects who are taking corticosteroids or other immunosuppressive drugs for other medical conditions concurrent malignancy requiring chemotherapy known renal insufficiency with glomerular filtration rate (egfr) < 30 ml/min (including patients receiving hemodialysis or hemofiltration). alt or ast > 5 times the upper limit of normal subjects receiving other immune-based therapy for covid-19, such as convalescent plasma, immunoglobulin products, interferons

Number of arms
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

3

Funding
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Saisei Pharma

Inclusion age min
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

100

Countries
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Ukraine

Type of patients
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Moderate/severe disease at enrollment

Severity scale
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

4: Moderate/severe disease at enrollment

Total sample size
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

600

primary outcome
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

14-day Participant Mortality;29-day Participant Mortality;The time to basic clinical improvement and to recovery defined as the following

Notes
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

Not reported

Arms
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 764, "treatment_name": "Maf capsules", "treatment_type": "Nutrition", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 772, "treatment_name": "M capsules", "treatment_type": "Nutrition", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]